SuperValu and Safeway: What the Company Knew, What the Payer Paid
Whistleblowers in the SuperValu and Safeway pharmacy pricing case alleged that the chains charged cash customers discounted prices while reporting higher usual-and-customary prices to Medicare and Medicaid payers. The Supreme Court rejected a defense that ignored what the companies believed when they billed. For a pharmacy insider, the story connects the counter price, the claim, the payment and the decisions behind them.
Whistleblowers brought the cases under the False Claims Act. In its June 1, 2023 opinion, the Supreme Court held that a reasonable interpretation offered later cannot erase what a company actually knew or believed when it submitted a claim. That ruling put the companies’ pricing instructions and internal discussions squarely in view.
The Cash Price and the Price Sent to the Payer
The alleged pricing gap arose when a discount offered at the pharmacy counter disappeared from the price reported for reimbursement. Usual-and-customary pharmacy prices matter because they can limit what a government health care program pays for a prescription.
The Supreme Court described how that works in these cases. Medicaid rules use the public price as one of the amounts that can cap healthcare reimbursement. Medicare Part D operates through private plan sponsors, which contract with pharmacies, sometimes through pharmacy benefit managers. Many of the contracts at issue limited reimbursement to the pharmacy’s usual-and-customary price. The claim carried a representation about what the pharmacy charged the public.
According to the whistleblowers’ account summarized in the opinion, Walmart’s low generic prices prompted SuperValu and Safeway to match competitors’ prices when customers asked. SuperValu then automatically applied the matched price to those customers’ future refills. Safeway also offered a membership discount program. Enrollment required basic information that, the whistleblowers argued, the pharmacy often already had.
A price retained for future refills reaches beyond the first request at the counter. The sales data showed why the whistleblowers challenged the higher reported price.
They presented evidence that discounted prices accounted for a majority of SuperValu’s cash sales for 44 of its 50 top-selling prescription drugs in 2012. For Safeway, they put discounted sales at 88% of cash sales for its top 20 generic drugs in 2014.
In the whistleblowers’ account, the price paid in most cash sales for those drugs was the exception. We would call that usual pricing turned upside down.
The Submitted Price and the Payment
The cash price, the submitted usual-and-customary price and the amount paid each answer a different question. The complaints’ examples show why a pricing case has to follow all three.
In the SuperValu amended complaint’s lovastatin example, the whistleblowers compared an April 30, 2011 cash purchase for $10 with an insured transaction on April 26. For that insured transaction, they alleged that SuperValu reported a usual-and-customary price of about $81 and received about $48.
In the Safeway complaint’s lisinopril example, dated September 28, 2011, the whistleblowers alleged a $4 cash price, a reported usual-and-customary price of about $12 and payment of about $6. The examples illustrate the billing theory, with the payer’s actual payment sitting between the cash price and the submitted price.
For an insider, the useful connection is how the payer’s rule treated the discount on the service date and what the reported field did to payment. The applicable contract, public-price definition and cash-sale population belong alongside the transaction. A price field is an input to the reimbursement calculation. The remittance shows the money.
What the Supreme Court Decided
The Supreme Court held that knowledge under the False Claims Act turns on what the company actually knew or believed when it billed. An interpretation someone could reasonably offer afterward cannot by itself settle that question. The rejected defense would have let a company that believed its claims were false rely on a reasonable reading offered later.
If a company understood that its discount price belonged in the claim, a later explanation for using the higher price does not wipe out that understanding. Ambiguous wording does not make an internal warning disappear.
The Instructions Behind the Price Field
The whistleblowers pointed to payer notices and internal communications as evidence that the chains understood the significance of their discounts. The Supreme Court’s account describes both companies receiving a pharmacy benefit manager’s notice in 2006 stating that usual and customary referred to discounted prices. Safeway also received that message from state Medicaid agencies, according to the account.
The internal discussions were more revealing than a price list. In emails quoted in the opinion, SuperValu executives described their discount program as a “stealthy approach” and expressed concern about the integrity of reported usual-and-customary prices. It also recounts Safeway instructions to match Walmart prices while keeping the instruction out of writing to stores because the company’s official policy said it did not match.
That is the tension the whistleblowers alleged: a price-matching operation inside the business and an official policy denying it. Someone responsible for pricing, reimbursement or store instructions may understand how those two accounts came apart.
The pharmacy’s operational records connect that understanding to a particular claim. Cash receipts and discount terms show what customers paid and who qualified. Pricing instructions and dated payer notices show what the business was told. Claim requests, responses and override histories show what its systems submitted and how the processor responded. Contracts and final remittances connect the reported price to reimbursement.
The comparison also depends on the medicine and transaction being matched. Product identifiers, quantity and days of supply describe what was billed. Product-code changes and rebilling can leave several versions of a prescription claim. We connect those versions and any reversals to the final payment, so the pricing story follows the transaction through the system.
This is where operational knowledge adds something an email alone cannot. An insider may know how the matched price carried into refills, which field the billing system sent, or how a payer response changed reimbursement. We work with that knowledge to connect the company’s decisions to the claims they affected.
Did the Supreme Court Award Damages Against SuperValu?
No. The Supreme Court’s ruling resolved the knowledge standard and sent the cases back. The later SuperValu trial produced a defense judgment, even though the jury found for the whistleblowers on knowledge. The district court’s October 31, 2025 post-trial order explains the split: the jury found for the whistleblowers on what SuperValu knew, but found they had not shown that the false claims caused the government’s loss.
Winning the argument about what the company knew did not establish that payment connection. That is why the cash sale, submitted price and reimbursement belong together in the case. The internal message explains a decision. The payment evidence connects that decision to what the program paid.
The Same Cash-Price Question in Kmart
Kmart faced a similar allegation that it left broadly available discounted generic prices out of usual-and-customary reporting. The appeals court’s treatment of its continuous discount programs as public prices shows why actual availability matters alongside the membership label.
The Justice Department’s December 22, 2017 announcement reported a $32.3 million federal settlement over those allegations, part of a $59 million global resolution. The announced whistleblower award was $9.3 million. A whistleblower case under the False Claims Act can pay the whistleblower 15% to 30% of what the government recovers.
You Know How the Price Reached the Claim
If you worked with cash discounts, payer pricing or the systems that turned them into claims, speak to one of our Whistleblower Experts about how the discount disappeared from the claim. We connect your pharmacy knowledge to the payment evidence and bring in pharmacy fraud whistleblower lawyers who understand reimbursement disputes. We stay beside you through the process to build your strongest pharmacy pricing whistleblower case.
